In 2004, Müller et al. [59] analyzed the hypermethylation of several genes and concluded that hypermethylation of the SFRP2 gene in stool samples can detect CRC with a sensitivity and specificity of 77–90% and 77%, respectively. This evidence concerns the gene SFRP2 and colorectal carcinoma.